Home » Stocks » HSTO

Histogen, Inc. (HSTO)

Stock Price: $1.51 USD -0.05 (-3.21%)
Updated November 24, 4:00 PM EST - Market closed
After-hours: $1.53 +0.02 (1.33%) Nov 24, 7:53 PM

Stock Price Chart

Key Info

Market Cap 25.55M
Revenue (ttm) 1.13M
Net Income (ttm) -19.63M
Shares Out 16.92M
EPS (ttm) -3.59
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 24
Last Price $1.51
Previous Close $1.56
Change ($) -0.05
Change (%) -3.21%
Day's Open 1.51
Day's Range 1.48 - 1.58
Day's Volume 86,526
52-Week Range 1.30 - 7.50

More Stats

Market Cap 25.55M
Enterprise Value 23.86M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 16.92M
Float 14.94M
EPS (basic) -3.59
EPS (diluted) -3.59
FCF / Share -0.82
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 65,912
Short Ratio 1.14
Short % of Float 0.44%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 22.63
PB Ratio 3.43
Revenue 1.13M
Operating Income -19.94M
Net Income -19.63M
Free Cash Flow -10.01M
Net Cash 1.69M
Net Cash / Share 0.10
Gross Margin 97.36%
Operating Margin -1,766.16%
Profit Margin -1,738.40%
FCF Margin -886.71%
ROA -82.09%
ROE -338.53%
ROIC -427.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$15.00*
Low
15.0
Current: $1.51
High
15.0
Target: 15.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014201320122011
Revenue21.7233.5935.380.80-----
Revenue Growth-35.34%-5.06%4327.66%------
Gross Profit21.7233.5935.380.80-----
Operating Income-12.01-18.28-17.55-29.83-24.13-22.29-11.60-8.61-12.36
Net Income-11.39-18.01-17.40-29.73-24.15-22.32-15.62-8.75-12.00
Shares Outstanding3.323.042.862.271.861.550.740.100.10
Earnings Per Share-3.40-5.90-6.10-13.10-13.00-14.40-6.30-86.00-118.60
Operating Cash Flow-20.20-34.86-33.2127.00-22.55-18.26-10.63-8.56-12.10
Capital Expenditures-0.01-0.07-0.03-0.11-0.09-0.24--0.02-0.02
Free Cash Flow-20.21-34.92-33.2326.89-22.63-18.50-10.64-8.58-12.11
Cash & Equivalents2.0840.6974.8577.0236.5137.0756.358.0316.76
Total Debt0.11-13.161.001.001.001.001.001.00
Net Cash / Debt1.9740.6961.7076.0235.5136.0755.357.0315.76
Assets2.9448.8081.9482.3239.7338.4556.948.1516.96
Liabilities1.8421.4053.9560.545.195.233.8266.4866.70
Book Value-37.0727.4028.0021.7934.5433.2153.12-58.34-49.74
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Histogen, Inc.
Country United States
Employees 22
CEO Richard W. Pascoe

Stock Information

Ticker Symbol HSTO
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: HSTO

Description

Histogen, a regenerative medicine company, develops therapies based upon the products of cells grown under simulated embryonic conditions. It offers human multipotent cell conditioned media (CCM); human extracellular matrix (hECM); and hair stimulating complex (HSC). The company's technology focuses on stimulating a patient's own stem cells by delivering a complex of multipotent human proteins that support stem cell growth and differentiation. Histogen Inc. is headquartered San Diego, California.